Changes are happening - please bear with us while we update our site.

Join Free
Log in

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

Join Free
Log in

Healthscope Ltd (HSO) Shareholders Receive Another Takeover Offer

Healthscope Ltd (ASX:HSO) has received another takeover offer, this one from Brookfield Asset Mangement for $2.50 per share.
Picture of Jaz Harrison

Jaz Harrison

Jaz is a Staff Writer for Rask. She is a keen investor who loves to thoroughly poke holes in an investment idea before it has a chance of making it into her portfolio. Jaz invests for the long-term and doesn't sweat the small stuff. She strongly believes that empowering people with knowledge is the best way for them to take charge of their finances, which is exactly the approach she takes with her own money and investments.
More analysis

Healthscope Ltd (ASX: HSO) shareholders received a boost on Wednesday when a second takeover offer came in from Brookfield Asset Management Inc.

Healthscope is the second biggest private hospital business in Australia and Brookfield is a global alternative asset manager with around US$285 billion in assets in management.

There is currently two takeover offers on the table for Healthscope. One offer from a consortium led by AustralianSuper and BGH Capital is for $2.36 per share and the new offer from Brookfield.

We covered the AustralianSuper led offer in more detail here: Is AustralianSuper & PE About To Buy Healthscope Ltd?

The Brookfield offer is $2.50 cash per share, which it said was a 23% premium to Healthscope’s closing price before the AustralianSuper consortium bid.

Brookfield is offering existing Healthscope shareholders an opportunity to invest alongside Brookfield in a privatised Healthscope as a significant minority position.

The proposal by Brookfield is subject to a number of conditions like due diligence, arranging debt finance for the purchase, approval by Brookfield’s investment committee, receiving all necessary regulatory approvals and a “level playing field condition”.

The Healthscope share price is up 2.8% since last Friday according to Google Finance.

Interested in finance and investing?

Did you know it’s free to join The Rask Group’s Investor Club Newsletter? It’s a regular (usually weekly) news and educational update on financial markets, investing and unique strategies. Join today and get ready to laugh and learn.

Click here to join The Rask Group’s Investor Club Newsletter Today

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Access all reports now

Unsubscribe anytime. Read our Terms, Financial Services Guide, Privacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Latest stories

Free passive income report
Skip to content